View of CHANGES IN BLOOD GLUCOSE LEVEL, GLYCOCYLATED HEMOGLOBIN LEVEL AND LIPID PROFILE AS A RESULT OF MONO-HYPOGLYCEMIC THERAPY (METFORMIN) IN TYPE II DIABETES MELLITUS

Return to Article Details CHANGES IN BLOOD GLUCOSE LEVEL, GLYCOCYLATED HEMOGLOBIN LEVEL AND LIPID PROFILE AS A RESULT OF MONO-HYPOGLYCEMIC THERAPY (METFORMIN) IN TYPE II DIABETES MELLITUS Download Download PDF